Privia Health Group's (PRVA) Sell (D+) Rating Reaffirmed at Weiss Ratings

Key Points

• Privia Health Group (PRVA) has had its sell (D+) rating reaffirmed by Weiss Ratings, despite several other analysts issuing more positive ratings.
• Currently, the stock holds an average target price of $28.58 and has experienced a 23.4% increase in revenue year over year.
• Institutional investors have significantly increased their holdings in Privia Health Group, with over 94% of the stock now owned by these investors.

Privia Health Group (NASDAQ:PRVA - Get Free Report)'s stock had its "sell (d+)" rating reissued by equities research analysts at Weiss Ratings in a research report issued to clients and investors on Wednesday,Weiss Ratings reports.

A number of other analysts have also commented on the company. Stephens reiterated an "overweight" rating and set a $32.00 price target on shares of Privia Health Group in a report on Wednesday, September 24th. Citigroup reiterated an "outperform" rating on shares of Privia Health Group in a report on Friday, August 29th. Evercore ISI dropped their price target on Privia Health Group from $30.00 to $28.00 and set an "outperform" rating on the stock in a report on Wednesday, July 9th. JMP Securities boosted their target price on Privia Health Group from $29.00 to $30.00 and gave the company a "market outperform" rating in a research note on Friday, August 29th. Finally, Piper Sandler lowered their target price on Privia Health Group from $36.00 to $35.00 and set an "overweight" rating on the stock in a research note on Monday, August 11th. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $28.58.

Privia Health Group Trading Up 2.2%

Shares of Privia Health Group stock opened at $24.53 on Wednesday. The business's fifty day simple moving average is $22.26 and its 200 day simple moving average is $22.45. The firm has a market capitalization of $3.01 billion, a P/E ratio of 223.02, a price-to-earnings-growth ratio of 3.28 and a beta of 0.83. Privia Health Group has a 12 month low of $16.47 and a 12 month high of $26.09.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.02 EPS for the quarter, missing analysts' consensus estimates of $0.05 by ($0.03). The business had revenue of $521.15 million for the quarter, compared to the consensus estimate of $466.97 million. Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%.The business's revenue was up 23.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.19 earnings per share. Privia Health Group has set its FY 2025 guidance at EPS. Analysts predict that Privia Health Group will post 0.14 EPS for the current fiscal year.

Institutional Trading of Privia Health Group

Hedge funds and other institutional investors have recently made changes to their positions in the stock. CWM LLC raised its stake in shares of Privia Health Group by 50.3% during the 1st quarter. CWM LLC now owns 1,804 shares of the company's stock valued at $40,000 after purchasing an additional 604 shares during the period. Bessemer Group Inc. raised its stake in shares of Privia Health Group by 2,393.4% during the 1st quarter. Bessemer Group Inc. now owns 2,269 shares of the company's stock valued at $51,000 after purchasing an additional 2,178 shares during the period. Russell Investments Group Ltd. raised its stake in shares of Privia Health Group by 2,852.2% during the 1st quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company's stock valued at $60,000 after purchasing an additional 2,567 shares during the period. GAMMA Investing LLC raised its stake in shares of Privia Health Group by 113.1% during the 1st quarter. GAMMA Investing LLC now owns 2,866 shares of the company's stock valued at $64,000 after purchasing an additional 1,521 shares during the period. Finally, Caitong International Asset Management Co. Ltd raised its stake in shares of Privia Health Group by 2,115.3% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 3,323 shares of the company's stock valued at $75,000 after purchasing an additional 3,173 shares during the period. 94.48% of the stock is currently owned by institutional investors.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.